Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

Roshini S. Abraham; Jerry A. Katzmann; Raynell J. Clark; A. R. Bradwell; Robert A. Kyle; Morie Gertz

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

Roshini S. Abraham, Jerry A. Katzmann, Raynell J. Clark, A. R. Bradwell, Robert A. Kyle, Morie Gertz

Research output: Contribution to journal › Article › peer-review

Abstract

Primary systemic amyloidosis is a plasma cell dyscrasia characterized by the accumulation of excess free immunoglobulin light chains (FLCs) as amyloid. One of the diagnostic features of amyloidosis is the presence of circulating monoclonal FLCs in the serum and urine of the patients. The FLC usually is present in small amounts, and immunofixation is required for detection. A nephelometric method for quantitating FLCs in serum has been described using antibodies that recognize only FLC not bound to heavy chain. We describe a retrospective study using this quantitative FLC method for assessing monoclonal FLCs in 95 patients with amyloidosis. The sensitivity of nephelometric serum FLC measurements is particularly useful in patients with negative immunofixation results for serum, urine, or both. In addition, the FLC assay can be used for follow-up of patients with amyloidosis who have undergone stem cell transplantation.

Original language	English (US)
Pages (from-to)	274-278
Number of pages	5
Journal	American Journal of Clinical Pathology
Volume	119
Issue number	2
State	Published - Feb 1 2003
Externally published	Yes

ASJC Scopus subject areas

Pathology and Forensic Medicine

Cite this

@article{f0d29c76007d494ab5a7f3f772b12b84,

title = "Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.",

abstract = "Primary systemic amyloidosis is a plasma cell dyscrasia characterized by the accumulation of excess free immunoglobulin light chains (FLCs) as amyloid. One of the diagnostic features of amyloidosis is the presence of circulating monoclonal FLCs in the serum and urine of the patients. The FLC usually is present in small amounts, and immunofixation is required for detection. A nephelometric method for quantitating FLCs in serum has been described using antibodies that recognize only FLC not bound to heavy chain. We describe a retrospective study using this quantitative FLC method for assessing monoclonal FLCs in 95 patients with amyloidosis. The sensitivity of nephelometric serum FLC measurements is particularly useful in patients with negative immunofixation results for serum, urine, or both. In addition, the FLC assay can be used for follow-up of patients with amyloidosis who have undergone stem cell transplantation.",

author = "Abraham, {Roshini S.} and Katzmann, {Jerry A.} and Clark, {Raynell J.} and Bradwell, {A. R.} and Kyle, {Robert A.} and Morie Gertz",

year = "2003",

month = feb,

day = "1",

language = "English (US)",

volume = "119",

pages = "274--278",

journal = "American Journal of Clinical Pathology",

issn = "0002-9173",

publisher = "American Society of Clinical Pathologists",

number = "2",

}

TY - JOUR

T1 - Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

AU - Abraham, Roshini S.

AU - Katzmann, Jerry A.

AU - Clark, Raynell J.

AU - Bradwell, A. R.

AU - Kyle, Robert A.

AU - Gertz, Morie

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Primary systemic amyloidosis is a plasma cell dyscrasia characterized by the accumulation of excess free immunoglobulin light chains (FLCs) as amyloid. One of the diagnostic features of amyloidosis is the presence of circulating monoclonal FLCs in the serum and urine of the patients. The FLC usually is present in small amounts, and immunofixation is required for detection. A nephelometric method for quantitating FLCs in serum has been described using antibodies that recognize only FLC not bound to heavy chain. We describe a retrospective study using this quantitative FLC method for assessing monoclonal FLCs in 95 patients with amyloidosis. The sensitivity of nephelometric serum FLC measurements is particularly useful in patients with negative immunofixation results for serum, urine, or both. In addition, the FLC assay can be used for follow-up of patients with amyloidosis who have undergone stem cell transplantation.

AB - Primary systemic amyloidosis is a plasma cell dyscrasia characterized by the accumulation of excess free immunoglobulin light chains (FLCs) as amyloid. One of the diagnostic features of amyloidosis is the presence of circulating monoclonal FLCs in the serum and urine of the patients. The FLC usually is present in small amounts, and immunofixation is required for detection. A nephelometric method for quantitating FLCs in serum has been described using antibodies that recognize only FLC not bound to heavy chain. We describe a retrospective study using this quantitative FLC method for assessing monoclonal FLCs in 95 patients with amyloidosis. The sensitivity of nephelometric serum FLC measurements is particularly useful in patients with negative immunofixation results for serum, urine, or both. In addition, the FLC assay can be used for follow-up of patients with amyloidosis who have undergone stem cell transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0037317755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037317755&partnerID=8YFLogxK

M3 - Article

C2 - 12579999

SN - 0002-9173

VL - 119

SP - 274

EP - 278

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

IS - 2

ER -

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this